Medicine and Dentistry
Neoplasm
98%
Meta-Analysis
86%
Abdominal Cancer
61%
Clear Cell Renal Cell Carcinoma
57%
Lung
40%
Odds Ratio
37%
Bladder
31%
Transitional Cell Carcinoma
31%
Immunohistochemistry
30%
Computer Assisted Tomography
30%
Metastatic Carcinoma
28%
Colorectal Carcinoma
28%
Malignant Neoplasm
28%
Hazard Ratio
27%
Diffuse Large B-Cell Lymphoma
26%
Gene Mutation
25%
Tumor Cell
25%
Guanidine
24%
Breast Cancer
24%
Protein Expression
24%
Lymph Node Metastasis
22%
Recurrent Disease
22%
Cancer
22%
Overall Survival
22%
Cell Cycle
22%
Prognostic Factor
22%
Epstein Barr Virus
22%
Papillary Thyroid Cancer
20%
Tumor Progression
20%
Tubulin
20%
Tissue Inhibitor of Metalloproteinase 1
20%
Mitosis Inhibition
20%
Fatty Acid Transporter 4
18%
Clinical Significance
17%
Chemotherapy
17%
Melanoma
17%
Diagnosis
17%
Recurrence Free Survival
16%
Chemosensitivity
15%
Stomach Adenocarcinoma
15%
Squamous Cell Carcinoma
15%
Spindle Checkpoint
15%
Prevalence
14%
Multiple Pulmonary Nodules
14%
Fatty Acid Transporter
14%
Fine-Needle Aspiration
13%
Carcinogenesis
13%
Precursor
13%
Cotransporter
13%
Mucinous Tumor
13%
Keyphrases
Meta-analysis
100%
Gastric Cancer
57%
Odds Ratio
45%
Clear Cell Renal Cell Carcinoma (ccRCC)
43%
Overexpression
39%
Clinicopathological Significance
37%
Tumor
34%
Colorectal Cancer
30%
Hazard Ratio
29%
Breast Cancer
29%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
26%
Upper Tract Urothelial Carcinoma
26%
Immunohistochemistry
26%
Diffuse Large B-cell Lymphoma (DLBCL)
25%
Renal Cell Carcinoma
25%
Tumor Cells
23%
Stomach
21%
Overall Survival
21%
Papillary Thyroid Carcinoma
20%
Prognostic Significance
20%
Tumor Progression
20%
Tubulin
20%
BRAF mutation
20%
CDC20
20%
Mitotic Arrest
20%
Immunohistochemical Staining
19%
Prognostic Factors
19%
Lymph Node Metastasis
19%
Fatty Acid Binding Protein 4 (FABP4)
18%
Survival Outcomes
17%
Older Men
17%
High-level Expression
16%
Borderline Tumor
16%
Gastrointestinal Stromal Tumor
16%
Expression Level
16%
Squamous Cell Carcinoma (SqCC)
16%
High-risk Human Papillomavirus (HR-HPV)
16%
Clinical Significance
15%
Recurrence-free Survival
15%
Immunohistochemical Study
15%
Spindle Assembly Checkpoint
15%
Multiple Pulmonary Nodules
15%
Protein Expression
14%
Multivariate Analysis
14%
Classical Hodgkin Lymphoma
14%
Prognostic Value
14%
Histological Subtypes
14%
Path Analysis
14%
Computed Tomography
14%
Histologic
14%